Andrew Bialecki compensation by year
Klaviyo Summary Compensation Table · all 3 fiscal years held| Component | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Salary | $75,000 | $75,000 | $75,000 |
| Bonus | — | $0 | $0 |
| Stock awards | — | $0 | $0 |
| Option awards | — | $0 | $0 |
| Non-equity incentive | — | $0 | $0 |
| Pension and deferred compensation | — | $0 | $0 |
| All other | $3,031 | $3,030 | $3,000 |
| Total | $78,031 | $78,030 | $78,000 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Klaviyo, Inc. DEF 14A filed April 29, 2026, accession 0001835830-26-000018, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Klaviyo, Inc. filed document, accession 0001835830-26-000018. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2026.
Insider transactions since the last proxy
10 Form 4 lines since the FY2025 proxy (filed April 29, 2026)current to 2026-11-07 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-05-26 | Conversion derivative | 10b5-1 | 212,529 | $0.00 | 66,731,589 |
| 2026-05-26 | Conversion | 10b5-1 | 212,529 | — | 212,529 |
| 2026-05-26 | Sale | 10b5-1 | 212,529 | $14.61 | 0 |
| 2026-05-19 | Conversion derivative | 10b5-1 | 200,000 | $0.00 | 66,944,118 |
| 2026-05-19 | Conversion | 10b5-1 | 200,000 | — | 200,000 |
| 2026-05-19 | Sale | 10b5-1 | 200,000 | $14.88 | 0 |
| 2026-05-12 | Sale | 10b5-1 | 58,684 | $14.97 | 141,316 |
| 2026-05-12 | Conversion | 10b5-1 | 200,000 | — | 200,000 |
The 8 most recent of 10 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments Klaviyo discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Involuntary termination without cause | $0 | $0 | $0 | $0 |
| Change in control and involuntary termination | $0 | $0 | $0 | $0 |
Per the Potential Payments Upon Termination or Change in Control table in Klaviyo, Inc.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
Klaviyo’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Steve Rowland | President | $8,538,174 |
| Amanda Whalen | Chief Financial Officer | $7,858,326 |
| Carmel Galvin | Chief People Officer | $5,093,084 |
| Landon Edmond | Chief Legal Officer and General Counsel | $5,082,204 |
| Andrew Bialecki · this page | Chief Executive Officer | $78,000 |
Board service
Klaviyo board · FY2023–FY2025How this board is paid
Company policy: Klaviyo pays directors a $37,000 cash retainer and $200,000 in RSUs. As stated in Klaviyo's FY2025 proxy.
The full Klaviyo compensation record
free company briefThis page is one person within Klaviyo's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Klaviyo proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Klaviyo's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Klaviyo's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order KVYO
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.